鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/08/21 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 6,100 |
| 2025/08/20 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 15,700 |
| 2025/08/19 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 21,700 |
| 2025/08/18 | 6,340 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 48,800 |
| 2025/08/15 | 6,330 | 6,340 | 6,320 | 6,340 | +10 | +0.2% | 48,800 |
| 2025/08/14 | 6,340 | 6,430 | 6,330 | 6,330 | -10 | -0.2% | 312,700 |
| 2025/08/13 | 6,330 | 6,420 | 6,330 | 6,340 | -10 | -0.2% | 48,600 |
| 2025/08/12 | 6,330 | 6,470 | 6,330 | 6,350 | +10 | +0.2% | 73,100 |
| 2025/08/08 | 6,330 | 6,340 | 6,320 | 6,340 | +10 | +0.2% | 22,100 |
| 2025/08/07 | 6,330 | 6,330 | 6,320 | 6,330 | ±0 | ±0% | 14,800 |
| 2025/08/06 | 6,330 | 6,330 | 6,320 | 6,330 | ±0 | ±0% | 8,700 |
| 2025/08/05 | 6,320 | 6,330 | 6,320 | 6,330 | +10 | +0.2% | 5,400 |
| 2025/08/04 | 6,330 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 6,000 |
| 2025/08/01 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 4,800 |
| 2025/07/31 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 17,300 |
| 2025/07/30 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 549,400 |
| 2025/07/29 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 14,500 |
| 2025/07/28 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 8,200 |
| 2025/07/25 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 15,600 |
| 2025/07/24 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 15,300 |
| 2025/07/23 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 12,500 |
| 2025/07/22 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 4,400 |
| 2025/07/18 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 8,400 |
| 2025/07/17 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 11,000 |
| 2025/07/16 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 24,600 |
| 2025/07/15 | 6,330 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 12,700 |
| 2025/07/14 | 6,330 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 8,400 |
| 2025/07/11 | 6,330 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 3,900 |
| 2025/07/10 | 6,330 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 17,400 |
| 2025/07/09 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 10,000 |
| 2025/07/08 | 6,330 | 6,340 | 6,320 | 6,320 | -10 | -0.2% | 20,800 |
| 2025/07/07 | 6,330 | 6,360 | 6,330 | 6,330 | +10 | +0.2% | 22,100 |
| 2025/07/04 | 6,330 | 6,330 | 6,320 | 6,320 | -10 | -0.2% | 18,200 |
| 2025/07/03 | 6,320 | 6,330 | 6,320 | 6,330 | ±0 | ±0% | 9,300 |
| 2025/07/02 | 6,320 | 6,330 | 6,320 | 6,330 | +10 | +0.2% | 30,500 |
| 2025/07/01 | 6,320 | 6,320 | 6,320 | 6,320 | ±0 | ±0% | 19,400 |
| 2025/06/30 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 31,400 |
| 2025/06/27 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 28,400 |
| 2025/06/26 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 52,100 |
| 2025/06/25 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 34,300 |
| 2025/06/24 | 6,330 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 90,900 |
| 2025/06/23 | 6,320 | 6,330 | 6,320 | 6,320 | -10 | -0.2% | 71,000 |
| 2025/06/20 | 6,330 | 6,330 | 6,320 | 6,330 | +10 | +0.2% | 64,300 |
| 2025/06/19 | 6,340 | 6,370 | 6,320 | 6,320 | -20 | -0.3% | 26,300 |
| 2025/06/18 | 6,330 | 6,420 | 6,330 | 6,340 | +10 | +0.2% | 48,400 |
| 2025/06/17 | 6,330 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 10,800 |
| 2025/06/16 | 6,340 | 6,350 | 6,340 | 6,340 | ±0 | ±0% | 26,100 |
| 2025/06/13 | 6,340 | 6,350 | 6,340 | 6,340 | ±0 | ±0% | 34,200 |
| 2025/06/12 | 6,340 | 6,350 | 6,330 | 6,340 | ±0 | ±0% | 92,500 |
| 2025/06/11 | 6,340 | 6,350 | 6,340 | 6,340 | ±0 | ±0% | 37,300 |
1～
50
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| キッセイ薬 | 429,000円 | +3.6% | - | 2.80% | 14.46倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| ペプチド | 151,600円 | +5.0% | +1.5% | 0.00% | 12.97倍 | 3.65倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サンバイオ | 250,600円 | - | - | 0.00% | - | 116.07倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 386,600円 | -6.4% | -71.8% | 4.91% | 43.06倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
